This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thermo Fisher Scientific Showcases Technologies To Improve Accuracy And Productivity In The Clinical Laboratory

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today showcased its comprehensive offering of specialty diagnostics products and analytical instruments designed to improve accuracy and productivity in clinical applications. The Thermo Scientific solutions are on display in booth 5140 during the Clinical Lab Expo at the American Association for Clinical Chemistry (AACC) conference, being held at the George R. Brown Convention Center in Houston from July 30 - August 1.

“Clinical laboratories are playing an ever-increasing role in supporting the diagnosis and monitoring of disease,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “Our goal is to develop new technologies and diagnostic tests that enable physicians to deliver better patient care at a lower cost.”

Better Tests for Informed Clinical Decisions

Thermo Fisher announced that its new Thermo Scientific QMS Tacrolimus immunoassay, unveiled at AACC last year, has received 510(k) clearance by the U.S. Food and Drug Administration. The liquid, ready-to-use immunoassay measures levels of tacrolimus on automated clinical chemistry analyzers, including the bench-top Thermo Scientific Indiko analyzer, to improve the quality of life for kidney, liver, and heart transplant patients.

The company also marked the debut of another FDA-cleared product, the Thermo Scientific MAS Omni•CARDIO controls, an assayed control serum comprising a combination of cardiac and associated critical markers for use in clinical laboratories to monitor assay conditions. The single test eliminates the need for separate quality control measures between tests and provides rapid results.

Leading Portfolio of Tools for Research Use Only

The new Thermo Scientific Sorvall ST 8 centrifuge reduces potential bottlenecks in the laboratory through its flexible, user-friendly design. The small bench-top centrifuge offers easy rotor exchange, an ability to spin several types of tubes simultaneously and integration with other tools, including microplates.

This year also marks the AACC introduction of Thermo Fisher’s landmark new offerings in chromatography and mass spectrometry. Its Thermo Scientific Prelude SPLC sample preparation and liquid chromatography system, combined with the new workhorse Thermo Scientific TSQ Endura triple-stage quadrupole mass spectrometer, provides the performance necessary for analysis of target compounds in complex biological matrices. The resulting workflow is easy to manage making LC-MS more widely accessible in clinical research laboratories.

For more information on new products introduced at AACC, please visit Thermo Scientific booth 5140 or the online media room at

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $13 billion, we have 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs